Urinary albumin-to-creatinine ratio for predicting risk of all-cause mortality and specific-cause mortality in patients with rheumatoid arthritis: evidence from NHANES 1999-2018
- PMID: 39738846
- DOI: 10.1007/s10067-024-07272-0
Urinary albumin-to-creatinine ratio for predicting risk of all-cause mortality and specific-cause mortality in patients with rheumatoid arthritis: evidence from NHANES 1999-2018
Abstract
Objective: To explore the relationship between urinary albumin-to-creatinine ratio (uACR) and all-cause/specific-cause mortality among patients with rheumatoid arthritis (RA).
Methods: This study included 1354 RA patients in the National Health and Nutritional Examination Surveys (NHANESs) during 1999-2018. The mortality status was assessed by linkage to death certificate data reported in the National Death Index (NDI) until December 31, 2019. Cox proportional hazards models and Kaplan-Meier (K-M) analysis were used to elucidate the relationship between uACR and all-cause/specific-cause mortality. Restricted cubic spline (RCS) was used to visualize the association of uACR with all-cause mortality risk. Stratified analyses were employed to identify patients with higher mortality risk.
Results: Over a median of 115 months of follow-up, 298 deaths occurred. Cox proportional hazards models indicated that RA patients with higher uACR had an increased risk of all-cause mortality, but not cardiovascular disease, kidney disease, and cancer mortality. K-M survival curves showed a significant difference (log-rank, p < 0.001) in all-cause mortality among uACR tertiles. RCS analysis revealed an L-shaped association between uACR and all-cause mortality, and patients with uACR above the threshold points (5.96 mg/g) had a 13.2% increased risk of all-cause mortality (HRs 1.132; 95% CI 1.011, 1.267) for each ln unit increase in uACR. The stratified analysis revealed consistent patterns for correlations between uACR and all-cause mortality.
Conclusions: High uACR, even in the normal range, was associated with an increased risk of all-cause mortality (not specific-cause mortality) in individuals with RA. Identifying high-risk populations using uACR assessment may contribute to target risk interventions among RA patients in the future. Key points • uACR, even within the normal range, significantly increased the hazard for all-cause mortality among RA patients. • uACR has good performance in identifying populations with different mortality risk levels in RA patients. • uACR, independent of varied well-recognized cardiovascular risk factors, is a predictor of mortality in RA patients.
Keywords: Mortality; Rheumatoid arthritis; Urinary albumin-to-creatinine ratio.
© 2024. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).
Conflict of interest statement
Compliance with ethical standards. Disclosures: None.
Similar articles
-
Association of urinary albumin excretion with all-cause and cardiovascular mortality among patients with rheumatoid arthritis: a national prospective study.Front Immunol. 2024 Sep 19;15:1412636. doi: 10.3389/fimmu.2024.1412636. eCollection 2024. Front Immunol. 2024. PMID: 39364405 Free PMC article.
-
The relationship between low levels of albuminuria and mortality among adults without major cardiovascular risk factors.Eur J Prev Cardiol. 2024 Dec 4;31(17):2046-2055. doi: 10.1093/eurjpc/zwae189. Eur J Prev Cardiol. 2024. PMID: 38825979 Free PMC article.
-
Association of the systemic immune-inflammation index with all-cause and cardiovascular mortality in individuals with rheumatoid arthritis.Sci Rep. 2024 Jul 2;14(1):15129. doi: 10.1038/s41598-024-66152-4. Sci Rep. 2024. PMID: 38956376 Free PMC article.
-
The relationship of vitamin D status to risk of cardiovascular disease and mortality.Dan Med J. 2015 Feb;62(2):B5008. Dan Med J. 2015. PMID: 25634511 Review.
-
Normoalbuminuria-is it normal? The association of urinary albumin within the 'normoalbuminuric' range with adverse cardiovascular and mortality outcomes: A systematic review and meta-analysis.Diabetes Obes Metab. 2024 Oct;26(10):4225-4240. doi: 10.1111/dom.15752. Epub 2024 Jul 17. Diabetes Obes Metab. 2024. PMID: 39021242
References
-
- McInnes IB, Schett G (2017) Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet 389(10086):2328–2337. https://doi.org/10.1016/S0140-6736(17)31472-1 - DOI - PubMed
-
- Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023–2038. https://doi.org/10.1016/S0140-6736(16)30173-8 - DOI - PubMed
-
- Figus FA, Piga M, Azzolin I, McConnell R, Iagnocco A (2021) Rheumatoid arthritis: extra-articular manifestations and comorbidities. Autoimmun Rev 20(4):102776. https://doi.org/10.1016/j.autrev.2021.102776 - DOI - PubMed
-
- Karstila K, Korpela M, Sihvonen S, Mustonen J (2007) Prognosis of clinical renal disease and incidence of new renal findings in patients with rheumatoid arthritis: follow-up of a population-based study. Clin Rheumatol 26(12):2089–2095. https://doi.org/10.1007/s10067-007-0625-y - DOI - PubMed
-
- Tokoroyama T, Ando M, Setoguchi K, Tsuchiya K, Nitta K (2017) Prevalence, incidence and prognosis of chronic kidney disease classified according to current guidelines: a large retrospective cohort study of rheumatoid arthritis patients. Nephrol Dial Transplant 32(12):2035–2042. https://doi.org/10.1093/ndt/gfw315 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical